Vfend and gamma-glutamyltransferase increased 
Vfend and gamma-glutamyltransferase increased Patient Reports February 12, 2012
Vfend Side Effects Report #5854442-8
Vfend side effect was reported by a Physician from JAPAN on Aug 12, 2008. Male patient, 75 years of age, was diagnosed with pulmonary mycosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, gamma-glutamyltransferase increased, transaminases increased. Vfend dosage: DAILY DOSE:400MG. Patient was hospitalized. Patient died on 08/01/2008.
Vfend Side Effects Report #5863684-7
Vfend side effect was reported by a Physician from JAPAN on Aug 19, 2008. Male patient, weighting 99.21 lb, was diagnosed with pulmonary mycosis, fungal infection
, bronchitis , diarrhoea, oedema, inflammation and was treated with Vfend. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood alkaline phosphatase increased, gamma-glutamyltransferase increased. Vfend dosage: unknown. During the same period patient was treated with URSO, FLOMOX, BIO THREE, ALBUMIN TANNATE, LASIX, PREDONINE. Patient was hospitalized. Patient died on 08/09/2008.Vfend Side Effects Report #4844900-7
Vfend side effect was reported by a Physician from JAPAN on Nov 15, 2005. Male patient, 75 years of age, was diagnosed with mycotic corneal ulcer, ulcerative keratitis and was treated with Vfend. After drug was administered, patient experienced the following side effects: corneal epithelium disorder, gamma-glutamyltransferase increased, malaise. Vfend dosage: 6 MG/KG, INTRAVENOUS. During the same period patient was treated with FLUCONAZOLE, PRODIF, FUNGUARD, GATIFLO, PIMARICIN. Patient recovered.
Vfend Side Effects Report #4847640-3
Vfend side effect was reported by a Physician from JAPAN on Nov 22, 2005. Male patient, 75 years of age, was diagnosed with mycotic corneal ulcer, ulcerative keratitis and was treated with Vfend. After drug was administered, patient experienced the following side effects: cardiac failure, cardiac valve disease, corneal epithelium disorder, corneal perforation, fluid retention, gamma-glutamyltransferase increased, malaise, nasopharyngitis, weight increased. Vfend dosage: 6MG/KG, INTRAVENOUS. During the same period patient was treated with FLUCONAZOLE, PRODIF, MICAFUNGIN, GATIFLOXACIN, NATAMYCIN. Patient recovered.
Vfend Side Effects Report #4865056-0
Vfend side effect was reported by a Physician from JAPAN on Dec 06, 2005. Male patient, 71 years of age, weighting 125.4 lb, was diagnosed with mycotic corneal ulcer, prophylaxis and was treated with Vfend. After drug was administered, patient experienced the following side effects: aortic valve incompetence, bifascicular block, bundle branch block left, bundle branch block right, cardiac failure, cardiac valve disease, fluid retention, gamma-glutamyltransferase increased, malaise. Vfend dosage: 320 MG (BID) INTRAVENOUS. During the same period patient was treated with FLUCONAZOLE, PRODIF, GATIFLOXACIN, SULPELIN, ATROPINE SULPHATE, TARAVID, ZOVIRAX, VANCOMYCIN. Patient recovered.
Vfend Side Effects Report #5605279-6
Vfend side effect was reported by a Health Professional from FRANCE on Jan 16, 2008. Male patient, child 4 years of age, was diagnosed with hepatosplenic candidiasis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, gamma-glutamyltransferase increased, inflammation, pyrexia. Vfend dosage: unknown. Patient recovered.
Vfend Side Effects Report #5619048-4
Vfend side effect was reported by a Health Professional from FRANCE on Jan 29, 2008. Male patient, child 4 years of age, was diagnosed with hepatosplenic candidiasis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, gamma-glutamyltransferase increased, inflammation, pyrexia. Vfend dosage: unknown. Patient recovered.
Vfend Side Effects Report #5717062-1
Vfend side effect was reported by a Health Professional from FRANCE on Apr 14, 2008. Male patient, weighting 35.27 lb, was diagnosed with hepatosplenic candidiasis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, gamma-glutamyltransferase increased, inflammation, pyrexia. Vfend dosage: unknown. During the same period patient was treated with BACTRIM, PREDNISONE, PARACETAMOL, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5725389-2
Vfend side effect was reported by a Health Professional from FRANCE on Apr 23, 2008. Male patient, weighting 35.27 lb, was diagnosed with hepatosplenic candidiasis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, gamma-glutamyltransferase increased, inflammation, pyrexia. Vfend dosage: unknown. During the same period patient was treated with BACTRIM, SOLUPRED, PARACETAMOL, OMEPRAZOLE, METRONIDAZOLE. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #4779458-4
Vfend side effect was reported by a Physician from UNITED STATES on Sept 13, 2005. Female patient, 57 years of age, weighting 90.00 lb, was diagnosed with fungal infection
and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, bone pain, gamma-glutamyltransferase increased, osteitis deformans. Vfend dosage: unknown. During the same period patient was treated with IMMUNOSUPPRESSIVE AGENTS. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #5150400-X
Vfend side effect was reported by a Pharmacist from JAPAN on Oct 25, 2006. Male patient, 71 years of age, was diagnosed with eye infection fungal and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with ITRACONAZOLE. Patient recovered.
Vfend Side Effects Report #5167217-2
Vfend side effect was reported by a Physician from JAPAN on Nov 20, 2006. Male patient, 71 years of age, was diagnosed with eye infection fungal and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with ITRACONAZOLE. Patient recovered.
Vfend Side Effects Report #5128302-4
Vfend side effect was reported by a Physician from JAPAN on Sept 28, 2006. Female patient, 71 years of age, weighting 108.9 lb, was diagnosed with bronchopulmonary aspergillosis, lung neoplasm malignant and was treated with Vfend. After drug was administered, patient experienced the following side effects: gamma-glutamyltransferase increased, hepatic function abnormal, malaise, nausea
, oral intake reduced. Vfend dosage: 400 MG (2 IN 1 D), ORAL; 300 MG, INTRAVENOUS. During the same period patient was treated with TAXOTERE, PARAPLATIN, ITRACONAZOLE. Patient recovered.Vfend Side Effects Report #5044556-7
Vfend side effect was reported by a Physician from JAPAN on June 16, 2006. Female patient, 61 years of age, weighting 114.2 lb, was diagnosed with bronchopulmonary aspergillosis, pneumocystis jiroveci pneumonia, sedation, pain
and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disseminated intravascular coagulation, gamma-glutamyltransferase increased, hepatic function abnormal, pneumonia , respiratory disorder. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE, DORMICUMECTION, LEPETAN, CARBENIN, MINOCYCLINE, ALENDRONATE, VIT K CAP, ZANTAC. Patient was hospitalized. Patient died on 05/17/2006.Vfend Side Effects Report #5045942-1
Vfend side effect was reported by a Physician from JAPAN on June 16, 2006. Female patient, 61 years of age, weighting 114.2 lb, was diagnosed with bronchopulmonary aspergillosis, pneumocystis jiroveci pneumonia, sedation, pain
and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, disseminated intravascular coagulation, gamma-glutamyltransferase increased, hepatic function abnormal, opportunistic infection. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE, DORMICUMECTION, LEPETAN, CARBENIN, MINOCYCLINE, ALENDRONATE, VIT K CAP, ZANTAC. Patient was hospitalized. Patient died on 05/17/2006.Vfend Side Effects Report #5154514-X
Vfend side effect was reported by a Physician from JAPAN on Oct 31, 2006. Female patient, 59 years of age, weighting 109.1 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood bilirubin increased, gamma-glutamyltransferase increased, hepatic enzyme increased, inappropriate antidiuretic hormone secretion. Vfend dosage: unknown. During the same period patient was treated with TACROLIMUS, PROGRAF, PREDNISOLONE, MUCOSOLVAN, GASTROM, SULFAMETHOXAZOLE, HOKUNALIN. Patient recovered.
Vfend Side Effects Report #5191726-3
Vfend side effect was reported by a Physician from JAPAN on Dec 06, 2006. Female patient, 59 years of age, weighting 109.1 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood bilirubin increased, gamma-glutamyltransferase increased, inappropriate antidiuretic hormone secretion, liver disorder. Vfend dosage: 600 MG (200 MG, 2 IN 1 D) ORAL; 400 MG (200 MG, 2 IN 1 D) ORAL. During the same period patient was treated with TACROLIMUS, PROGRAF, PREDNISOLONE, MUCOSOLVAN, GASTROM, SULFAMETHOXAZOLE, HOKUNALIN. Patient recovered.
Vfend Side Effects Report #5288916-8
Vfend side effect was reported by a Health Professional from FRANCE on Apr 02, 2007. Male patient, 56 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatosplenomegaly, jaundice
, pyrexia. Vfend dosage: unknown. During the same period patient was treated with CYTARABINE, VANCOMYCIN, ESOMEPRAZOLE MAGNESIUM, DIHYDROERGOTAMINE MESYLATE, CIPROFLOXACIN, PIPERACILLIN, PARACETAMOL, RITUXIMAB. Patient died on 06/23/2006.Vfend Side Effects Report #5651791-3
Vfend side effect was reported by a Physician from FRANCE on Feb 22, 2008. Male patient, weighting 103.6 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, gamma-glutamyltransferase increased. Vfend dosage: DAILY DOSE:400MG. During the same period patient was treated with TRANDOLAPRIL, DIFFU K, ALDACTONE, DIGOXIN, SEREVENT, CORTANCYL. Patient died.
Vfend Side Effects Report #6018843-X
Vfend side effect was reported by a Health Professional from JAPAN on Dec 11, 2008. Female patient was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, toxic epidermal necrolysis. Vfend dosage: 200 MG, 2X/DAY. During the same period patient was treated with ADONA, TRANSAMIN. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #6048343-2
Vfend side effect was reported by a Health Professional from JAPAN on Jan 13, 2009. Female patient was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, toxic epidermal necrolysis. Vfend dosage: 200 MG, 2X/DAY. During the same period patient was treated with ADONA, TRANSAMIN. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5019747-1
Vfend side effect was reported by a Physician from JAPAN on May 22, 2006. Female patient, 61 years of age, was diagnosed with aspergillosis, brain abscess and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, gamma-glutamyltransferase increased, hepatic function abnormal, myelodysplastic syndrome. Vfend dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, MICAFUNGIN. Patient died.
Vfend Side Effects Report #5750134-4
Vfend side effect was reported by a Consumer or non-health professional from FRANCE on May 15, 2008. Male patient, 35 years of age, was diagnosed with aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: agitation, blood alkaline phosphatase increased, blood bilirubin increased, coma, confusional state, cytolytic hepatitis, gamma-glutamyltransferase increased, hypovolaemia. Vfend dosage: unknown. During the same period patient was treated with AZITHROMYCIN, PREDNISONE, SULFAMETHOXAZOLE, BROMAZEPAM. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5745716-X
Vfend side effect was reported by a Physician from FRANCE on May 14, 2008. Male patient was diagnosed with aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: agitation, blood bilirubin increased, coma, confusional state, cytolytic hepatitis, gamma-glutamyltransferase increased, neurotoxicity, suicide attempt. Vfend dosage: unknown. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #4780943-X
Vfend side effect was reported by a Physician from JAPAN on Sept 05, 2005. Male patient, 65 years of age, was diagnosed with aspergilloma, diabetes mellitus and was treated with Vfend. After drug was administered, patient experienced the following side effects: alcohol use, gamma-glutamyltransferase increased. Vfend dosage: 200 MG, ORAL. Patient recovered.
Vfend Side Effects Report #4788912-0
Vfend side effect was reported by a Physician from JAPAN on Sept 21, 2005. Male patient, 64 years of age, was diagnosed with aspergilloma, diabetes mellitus and was treated with Vfend. After drug was administered, patient experienced the following side effects: alcohol use, gamma-glutamyltransferase increased. Vfend dosage: 200 MG , ORAL. Patient recovered.
Vfend Side Effects Report #5146288-3
Vfend side effect was reported by a Physician from JAPAN on Oct 19, 2006. Male patient, 87 years of age, was treated with Vfend. After drug was administered, patient experienced the following side effects: aspergillosis, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, gamma-glutamyltransferase increased, hepatic function abnormal, interstitial lung disease. Vfend dosage: 400 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, IMMUNOSUPPRESSIVE AGENTS. Patient died on 10/01/2006.
Vfend Side Effects Report #5665007-5
Vfend side effect was reported by a Physician from JAPAN on Mar 03, 2008. Female patient, 27 years of age, was treated with Vfend. After drug was administered, patient experienced the following side effects: blood bilirubin increased, gamma-glutamyltransferase increased, prothrombin level decreased, pyrexia. Vfend dosage: DAILY DOSE:400MG. Patient recovered.
Vfend Side Effects Report #5717086-4
Vfend side effect was reported by a Physician from JAPAN on Apr 16, 2008. Female patient, 27 years of age, was treated with Vfend. After drug was administered, patient experienced the following side effects: blood bilirubin increased, gamma-glutamyltransferase increased, prothrombin level decreased, pyrexia. Vfend dosage: DAILY DOSE:400MG. Patient recovered.
Vfend Side Effects Report #6088403-3
Vfend side effect was reported by a Consumer or non-health professional from JAPAN on Feb 12, 2009. Female patient was treated with Vfend. After drug was administered, patient experienced the following side effects: blood triglycerides increased, gamma-glutamyltransferase increased. Vfend dosage: unknown. During the same period patient was treated with VESANOID. Patient recovered.
Vfend Side Effects Report #6100270-8
Vfend side effect was reported by a Consumer or non-health professional from JAPAN on Feb 19, 2009. Female patient was treated with Vfend. After drug was administered, patient experienced the following side effects: blood triglycerides increased, gamma-glutamyltransferase increased. Vfend dosage: unknown. During the same period patient was treated with VESANOID. Patient recovered.